News

Today, we announce that MetaGene partners with Rare Cancers Australia. Richard Holder CEO of MetaGene announced that the company has partnered with Rare Cancers Australia (RCA) to be the  charity of choice. “The support of our customers during our Ducks in a Row Campaign at DIHC 2018...

Work done by Dr. Joseph, Medical Director, Department of Pathology and Laboratory Medicine, Lowell General Hospital highlights results of a comparison study between manual and computer-aided analysis for the scoring of PD-L1 in non-small cell lung cancer (NSCLC) tissue samples. Digital interpretation was found to overcome manual...

MetaGene and Applied Spectral Imaging (ASI) are proud to offer Australia's first QDP-IHC Section and support the Menzies Health Institute Queensland in the creation of the country’s first Quantitative Digital Pathology – Immunohistochemistry Section (QDP-IHC). This department will utilise the GenASIs Digital Pathology platform, approved...

[video width="640" height="360" mp4="https://metagene.com.au/wp-content/uploads/2017/10/MetaGene_7NewsBrisbane_26102017.mp4"][/video]   Diagnostic digital pathology system improving the landscape of cancer diagnosis In an Australian first, the Federal Government has granted TGA approval for a diagnostic digital pathology system set to radically improve the outlook for cancer patients through rapid and accurate diagnosis. MetaGene has received...

With increasing requests from clients for suppliers to offer educational content within research institutes, Melissa, MetaGene's Technical Specialist, delivered training on Biocare's 2012 NxGen Decloaking Chamber in the core histology laboratory of the Westmead Institute for Medical Research in mid-July. The training outlining safety and...

Applied Spectral Imaging (ASI) announces that its HiPath™ IHC imaging and analysis system provides computer-assisted PD-L1 interpretation. PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in determining the treatment for patients with...

We are excited to announce that we are now the Australian distributer of Nordic Biosite. Nordic Biosite Boast a 1,500,000-item product catalogue covering diagnostic antibodies to life science research reagents. Now in business for nearly 20 years, Nordic BioSite is recognised as a leader in supply of products for...